Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Higher complication rate for oxaliplatin compared to mitomycin C

Acta Chirurgica Belgica

Volumn 106, Issue 3, 2006, Pages 302-306

  Rouers, A ^a,b   Laurent, S ^a   Detroz, B ^a   Meurisse, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE   (Belgium)

Author keywords

Colorectal cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Mitomycin C; Oxaliplatin; Peritoneal carcinomatosis

Indexed keywords

EID: 33745896838     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2006.11679897     Document Type: Article

References (23)

1. PARKIN D. M., PISANI P., FERLAY J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80 (6): 827-41.
2. CHU D. Z., LANG N. P., THOMPSON C., OSTEEN P. K., WESTBROOK K. C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer, 1989, 63 (2): 364-7.
3. SADEGHI B., ARVIEUX C., GLEHEN O. et al Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer, 2000, 88 (2): 358-63.
4. SUGARBAKER P. H., CUNLIFFE W. J., BELLIVEAU J. et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol, 1989, 16 (4 Suppl 6): 83-97.
5. ELIAS D., BLOT F., EL OTMANY A. et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer, 2001, 92 (1): 71-6.
6. DETROZ B., LAURENT S., HONORE P. et al. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis. Acta Chir Belg, 2004, 104 (4): 377-83.
7. ELIAS D., MATSUHISA T., SIDERIS L. et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol, 2004, 15 (10) : 1558-65.
8. SUGARBAKER P. H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol, 1998, 14 (3): 254-61.
9. SHEN P., HAWKSWORTH J., LOVATO J. et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol, 2004, 11 (2): 178-86.
10. SUGARBAKER P. H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol, 1999, 43 Suppl: S15-S25.
11. SUGARBAKER P. H., SCHELLINX M. E., CHANG D., KOSLOWE P., VON MEYERFELDT M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg, 1996, 20 (5): 585-91.
12. EILBER F. C., ROSEN G., FORSCHER C. et al. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol, 1999, 6 (7): 645-50.
13. HALLER D. G. Chemotherapy in gastrointestinal malignancies. Semin Oncol, 1988, 15 (3 Suppl 4): 50-64.
14. STORM F. K. Clinical hyperthermia and chemotherapy. Radiol Clin North Am, 1989, 27 (3): 621-7.
15. ANDRE T., BONI C., MOUNEDJI-BOUDIAF L. et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 2004, 350 (23): 2343-51.
16. PESTIEAU S. R., BELLIVEAU J. F., GRIFFIN H. et al. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies. J Surg Oncol, 2001, 76 (2): 106-14.
17. ELIAS D., BONNAY M., PUIZILLOU J. M. et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol, 2002, 13 (2): 267-72.
18. ELIAS D., SIDERIS L., POCARD M. et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol, 2004, 15 (5): 781-5.
19. VERWAAL V. J., VAN TINTEREN H., RUTH S. V. et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol, 2004, 85 (2): 61-7.
20. MAKRIN V., LEV-CHELOUCHE D., EVEN SAPIR E. et al. Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. J Surg Oncol, 2005, 89 (1): 18-22.
21. VAN DER KOLK B. M., DE MAN B. M., WOBBES T. et al. Is early postoperative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine? Br J Cancer, 1999, 79 (3-4): 45-50.
22. DINDO D., DEMARTINES N., CLAVIEN P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004, 240 (2): 205-13.
23. GLEHEN O., KWIATKOWSKI F., SUGARBAKER P. H. et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: amulti-institutional study. J Clin Oncol, 2004, 22 (16): 3284-92.